Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Operations: 2019-2025

Historic Cash from Operations for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $2.3 million.

  • Burning Rock Biotech's Cash from Operations rose 114.52% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.5 million, marking a year-over-year decrease of 1749.64%. This contributed to the annual value of -$12.6 million for FY2024, which is 64.91% up from last year.
  • Burning Rock Biotech's Cash from Operations amounted to $2.3 million in Q3 2025, which was up 103.39% from -$67.9 million recorded in Q2 2025.
  • Over the past 5 years, Burning Rock Biotech's Cash from Operations peaked at $19.1 million during Q1 2024, and registered a low of -$239.8 million during Q3 2023.
  • For the 3-year period, Burning Rock Biotech's Cash from Operations averaged around -$38.8 million, with its median value being -$15.9 million (2024).
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 1,632.50% in 2021, then spiked by 215.74% in 2024.
  • Burning Rock Biotech's Cash from Operations (Quarterly) stood at -$17.6 million in 2021, then spiked by 46.00% to -$9.5 million in 2022, then surged by 76.30% to -$2.3 million in 2023, then surged by 215.74% to $2.6 million in 2024, then soared by 114.52% to $2.3 million in 2025.
  • Its Cash from Operations stands at $2.3 million for Q3 2025, versus -$67.9 million for Q2 2025 and -$23.5 million for Q1 2025.